Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2015
Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A M Vannucchi, T Barbui, F Cervantes, et al.
Leukemia
|
August 15, 2013
Expression of the lymphoid enhancer factor 1 is required for normal hematopoietic stem and progenitor cell function
K E Edmaier, K Stahnke, N Vegi, et al.
Blood
|
April 6, 2001
Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo
C Buske, M Feuring-Buske, J Antonchuk, et al.
British Journal of Haematology
|
August 30, 2006
Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO
F Kuchenbauer, S Schnittger, T Look, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B Eichhorst, P Ghia, C U Niemann, et al.
Annals of Hematology
|
September 1, 1996
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells
G G Wulf, G Jahns-Streubel, F Strutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Leukemia
|
November 22, 1997
In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand
C Buske, A Twiling, G Gogowski, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2015
Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A M Vannucchi, T Barbui, F Cervantes, et al.
Leukemia
|
August 15, 2013
Expression of the lymphoid enhancer factor 1 is required for normal hematopoietic stem and progenitor cell function
K E Edmaier, K Stahnke, N Vegi, et al.
Blood
|
April 6, 2001
Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo
C Buske, M Feuring-Buske, J Antonchuk, et al.
British Journal of Haematology
|
August 30, 2006
Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO
F Kuchenbauer, S Schnittger, T Look, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
B Eichhorst, P Ghia, C U Niemann, et al.
Annals of Hematology
|
September 1, 1996
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells
G G Wulf, G Jahns-Streubel, F Strutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2018
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Kastritis, V Leblond, M A Dimopoulos, et al.
Leukemia
|
November 22, 1997
In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand
C Buske, A Twiling, G Gogowski, et al.
Page
of 10